Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Harland

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
The Lancet. Haematology|July 5, 2022
COVID-19 vaccination antibody responses in patients with aplastic anaemia and paroxysmal nocturnal haemoglobinuriaAlexandra Pike, Claire McKinley, Briony Forrest, et al.
Journal of Medical Genetics|December 20, 2022
Population-based analysis of <i>POT1</i> variants in a cutaneous melanoma case-control cohortIrving Simonin-Wilmer, Raul Ossio, Emmett M Leddin, et al.
Pigment Cell & Melanoma Research|June 12, 2013
Evaluation of PAX3 genetic variants and nevus numberZighereda Ogbah, Celia Badenas, Mark Harland, et al.
The Journal of Pathology|October 11, 2022
Mutually exclusive genetic interactions and gene essentiality shape the genomic landscape of primary melanomaSofia Birkeälv, Mark Harland, Larissa Satiko Alcantara Sekimoto Matsuyama, et al.
The Journal of Investigative Dermatology|June 18, 2013
Somatic BRAF and NRAS mutations in familial melanomas with known germline CDKN2A status: a GenoMEL studyAbdlsattar Zebary, Katarina Omholt, Remco van Doorn, et al.
Cancer Research|February 19, 2019
Genetic and Environmental Determinants of Immune Response to Cutaneous MelanomaJoanna Poźniak, Jérémie Nsengimana, Jonathan P Laye, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2008
A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL)Mark Harland, Alisa M Goldstein, Kairen Kukalizch, et al.
Pigment Cell & Melanoma Research|February 14, 2012
Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL studyJohn R Davies, Juliette Randerson-Moor, Kairen Kukalizch, et al.
Ebiomedicine|August 25, 2022
Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanomaNiccolò Rossi, Karla A Lee, Maria V Bermudez, et al.
Journal of Medical Genetics|February 18, 2011
Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UKAnne E Cust, Mark Harland, Enes Makalic, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
The Lancet. Haematology|July 5, 2022
COVID-19 vaccination antibody responses in patients with aplastic anaemia and paroxysmal nocturnal haemoglobinuriaAlexandra Pike, Claire McKinley, Briony Forrest, et al.
Journal of Medical Genetics|December 20, 2022
Population-based analysis of <i>POT1</i> variants in a cutaneous melanoma case-control cohortIrving Simonin-Wilmer, Raul Ossio, Emmett M Leddin, et al.
Pigment Cell & Melanoma Research|June 12, 2013
Evaluation of PAX3 genetic variants and nevus numberZighereda Ogbah, Celia Badenas, Mark Harland, et al.
The Journal of Pathology|October 11, 2022
Mutually exclusive genetic interactions and gene essentiality shape the genomic landscape of primary melanomaSofia Birkeälv, Mark Harland, Larissa Satiko Alcantara Sekimoto Matsuyama, et al.
The Journal of Investigative Dermatology|June 18, 2013
Somatic BRAF and NRAS mutations in familial melanomas with known germline CDKN2A status: a GenoMEL studyAbdlsattar Zebary, Katarina Omholt, Remco van Doorn, et al.
Cancer Research|February 19, 2019
Genetic and Environmental Determinants of Immune Response to Cutaneous MelanomaJoanna Poźniak, Jérémie Nsengimana, Jonathan P Laye, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2008
A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL)Mark Harland, Alisa M Goldstein, Kairen Kukalizch, et al.
Pigment Cell & Melanoma Research|February 14, 2012
Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL studyJohn R Davies, Juliette Randerson-Moor, Kairen Kukalizch, et al.
Ebiomedicine|August 25, 2022
Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanomaNiccolò Rossi, Karla A Lee, Maria V Bermudez, et al.
Journal of Medical Genetics|February 18, 2011
Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UKAnne E Cust, Mark Harland, Enes Makalic, et al.
Pageof 8